Showing 381-390 of 2293 results for "".
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/30981/Eli Lilly Implements Transparent Physician Payment PolicyEli Lilly has announced a pioneering initiative to enhance transparency in its financial interactions with healthcare professionals. Starting in the latter half of 2009, Lilly will publicly disclose payments exceeding $500 made to physicians f
- When Life Is "Fragrance-Free" — Taste & Smell Disorders In Clinical Neurologyhttps://practicalneurology.com/columns/practice-management/when-life-is-fragrance-free-taste-smell-disorders-in-clinical-neurology/31067/Taste and Smell Disorders: Emerging Concerns in Clinical NeurologyTaste and smell disorders are increasingly recognized within clinical neurology, expanding beyond their traditional focus in otorhino-laryngology. Dr. Ronald Devere underscores the rising prevalence of these sensory impairments in var
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31229/Recent developments in vascular disease management and neurology highlight both challenges and advancements crucial for healthcare professionals. The FDA, in collaboration with Baxter, issued a warning regarding delayed onset heparin-induced thrombocytopenia (HIT) and thrombosis (HITT) associated wi
Frontotemporal Dementias
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/frontotemporal-dementias/31537/Careful clinical, neuropsychologic, and imaging investigations make differential diagnosis of variants possible.Parkinson Disease Treatment Advances
https://practicalneurology.com/diseases-diagnoses/movement-disorders/parkinson-disease-treatment-advances/31935/New agents, formulations, and procedures to improve Parkinson disease treatment.Fatigue in Multiple Sclerosis: A Comprehensive Approach to Evaluation and Management
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/fatigue-in-multiple-sclerosis-a-comprehensive-approach-to-evaluation-and-management/32087/Management of fatigue in multiple sclerosis requires a holistic approach tailored to the individual.Headache Medicine Update: What’s New in CGRP Functional Blocking Agents
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-medicine-update-whats-new-in-cgrp-functional-blocking-agents/32126/CGRP blocking agents have demonstrated success in migraine treatment and can be used in various settings, in different combinations, and for different headache conditions.Diversity in Aging-Related Neuroimaging Research
https://practicalneurology.com/diseases-diagnoses/imaging-testing/diversity-in-aging-related-neuroimaging-research/31761/There is a truly critical need to eliminate underrepresentation in aging-related neuroimaging research.Circulating Biomarkers in Diffuse Gliomas: Current Landscape and Future Directions
https://practicalneurology.com/diseases-diagnoses/neuro-oncology/circulating-biomarkers-in-diffuse-gliomas-current-landscape-and-future-directions/32102/Liquid biopsy holds promise as a less-invasive diagnostic and disease-monitoring strategy in the clinical care of people with glioma.Anti-N-Methyl D Aspartate Receptor Encephalitis
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/anti-n-methyl-d-aspartate-receptor-encephalitis/31705/Encephalitis caused by antibodies to the N-methyl-D-aspartate receptor causes symptoms of movement disorders, seizure, and psychiatric disturbances.